Amarin | AMRN - Acreedores Comerciales

Precio De Mercado
14.31
Cambio Diario
-0.28 -1.92%
Mensual
-2.52%
Anual
37.20%
Q2 Expectativa
13.88




Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 45.36M 8.64M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Esperion Therapeutics USD 65.07M 12.44M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12